LEADER 02101nas  2200601-a 450 
001 996336652303316
005 20221219182110.0
011   $a1748-233X
035   $a(OCoLC)70297038
035   $a(CKB)1000000000224311
035   $a(CONSER)--2006249130
035   $a(EXLCZ)991000000000224311
100   $a20060713b20062008  s--            a
101 0 $aeng
135   $aurc|u||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aProgress in neurotherapeutics and neuropsychopharmacology
210   $aCambridge [England] $cCambridge University Press$d2006-2008
215   $a1 online resource
300   $aRefereed/Peer-reviewed
300   $aTitle from journal homepage (publisher's Web site, viewed July 12, 2006).
311   $a1748-2321 
517 3 $aNeurotherapeutics and neuropsychopharmacology
606   $aNeuropsychopharmacology$vPeriodicals
606   $aNeurobehavioral disorders$vPeriodicals
606   $aNeurology$vPeriodicals
606   $aNeurobehavioral disorders$2fast$3(OCoLC)fst01036314
606   $aNeurology$2fast$3(OCoLC)fst01036390
606   $aNeuropsychopharmacology$2fast$3(OCoLC)fst01036504
606   $aBrain Diseases$xdrug therapy
606   $aNeuropharmacology
606   $aCentral Nervous System$xdrug effects
606   $aClinical Trials as Topic
606   $aMental Disorders$xdrug therapy
608   $aPeriodicals.$2fast
610   $aPharmacy, Therapeutics, & Pharmacology
615  0$aNeuropsychopharmacology
615  0$aNeurobehavioral disorders
615  0$aNeurology
615  7$aNeurobehavioral disorders.
615  7$aNeurology.
615  7$aNeuropsychopharmacology.
615 12$aBrain Diseases$xdrug therapy.
615 12$aNeuropharmacology.
615 22$aCentral Nervous System$xdrug effects.
615 22$aClinical Trials as Topic.
615 22$aMental Disorders$xdrug therapy.
906   $aJOURNAL
912   $a996336652303316
996   $aProgress in neurotherapeutics and neuropsychopharmacology$91906764
997   $aUNISA